US Stock MarketDetailed Quotes

SGMO Sangamo Therapeutics

Watchlist

0.562
+0.018+3.31%

Trading May 2 09:31 ET

116.57MMarket Cap-379P/E (TTM)

Sangamo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Total revenue

58.34%176.23M

-92.50%2.04M

-64.48%9.4M

-76.73%6.84M

459.52%157.96M

0.54%111.3M

-2.70%27.23M

-7.36%26.46M

5.40%29.38M

7.42%28.23M

Operating revenue

58.34%176.23M

-92.50%2.04M

-64.48%9.4M

-76.73%6.84M

459.52%157.96M

0.54%111.3M

-2.70%27.23M

-7.36%26.46M

5.40%29.38M

7.42%28.23M

Cost of revenue

Gross profit

Operating expense

-5.55%295.22M

-22.77%63.81M

-12.72%71.01M

5.26%79.06M

10.70%81.35M

6.31%312.58M

21.71%82.62M

5.66%81.35M

-1.91%75.11M

1.25%73.49M

Selling and administrative expenses

-2.42%61.17M

-20.34%13.1M

-14.29%13.92M

6.10%16.01M

21.65%18.14M

-0.85%62.68M

2.23%16.44M

11.98%16.24M

-8.45%15.09M

-7.68%14.91M

-General and administrative expense

-2.42%61.17M

-20.34%13.1M

-14.29%13.92M

6.10%16.01M

21.65%18.14M

-0.85%62.68M

2.23%16.44M

11.98%16.24M

-8.45%15.09M

-7.68%14.91M

Research and development costs

-6.34%234.06M

-23.38%50.71M

-12.33%57.09M

5.04%63.05M

7.91%63.22M

8.27%249.9M

27.76%66.18M

4.19%65.12M

-0.11%60.02M

3.81%58.58M

Operating profit

40.88%-118.99M

-11.50%-61.76M

-12.23%-61.61M

-57.92%-72.23M

269.25%76.61M

-9.79%-201.28M

-38.83%-55.39M

-13.33%-54.89M

6.09%-45.73M

2.25%-45.26M

Net non-operating interest income expense

17.71%11.1M

-59.43%1.49M

98.70%3.52M

6.02%2.8M

145.38%3.29M

76.43%9.43M

57.45%3.68M

112.11%1.77M

70.52%2.64M

114.72%1.34M

Non-operating interest income

17.71%11.1M

-59.43%1.49M

98.70%3.52M

----

76.43%9.43M

--3.68M

--1.77M

----

Total other finance cost

----

-6.02%-2.8M

-145.38%-3.29M

----

-70.52%-2.64M

-114.72%-1.34M

Other net income (expense)

-155.01M

-296K

-44.8M

-51.35M

-58.57M

Special income (charges)

---155.01M

---296K

---44.8M

---51.35M

---58.57M

--0

-Less:Impairment of capital assets

--155.01M

--296K

--44.8M

--51.35M

--58.57M

--0

Income before tax

-37.04%-262.9M

-17.12%-60.57M

-93.68%-102.89M

-180.27%-120.77M

148.56%21.33M

-7.79%-191.85M

-37.67%-51.71M

-11.60%-53.13M

8.61%-43.09M

3.85%-43.92M

Income tax

-1,282.28%-5.07M

-205.02%-272K

4,133.33%1.27M

-7,739.02%-6.26M

234.48%194K

40.20%429K

486.57%259K

-65.12%30K

241.67%82K

-77.86%58K

Net income

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.84%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.48%-43.17M

4.27%-43.98M

Net income continuous Operations

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.84%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.48%-43.17M

4.27%-43.98M

Minority interest income

Net income attributable to the parent company

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.85%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.47%-43.17M

4.26%-43.98M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-34.09%-257.83M

-16.01%-60.3M

-95.96%-104.16M

-165.23%-114.51M

148.05%21.13M

-7.85%-192.28M

-38.61%-51.97M

-11.46%-53.16M

8.47%-43.17M

4.26%-43.98M

Basic earnings per share

-18.40%-1.48

-6.25%-0.34

-73.53%-0.59

-127.59%-0.66

143.33%0.13

-1.63%-1.25

-23.08%-0.32

-3.03%-0.34

12.12%-0.29

6.25%-0.3

Diluted earnings per share

-18.40%-1.48

-6.25%-0.34

-73.53%-0.59

-127.59%-0.66

140.00%0.12

-1.63%-1.25

-23.08%-0.32

-3.03%-0.34

12.12%-0.29

6.25%-0.3

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Total revenue	58.34%176.23M	-92.50%2.04M	-64.48%9.4M	-76.73%6.84M	459.52%157.96M	0.54%111.3M	-2.70%27.23M	-7.36%26.46M	5.40%29.38M	7.42%28.23M
Operating revenue	58.34%176.23M	-92.50%2.04M	-64.48%9.4M	-76.73%6.84M	459.52%157.96M	0.54%111.3M	-2.70%27.23M	-7.36%26.46M	5.40%29.38M	7.42%28.23M
Cost of revenue
Gross profit
Operating expense	-5.55%295.22M	-22.77%63.81M	-12.72%71.01M	5.26%79.06M	10.70%81.35M	6.31%312.58M	21.71%82.62M	5.66%81.35M	-1.91%75.11M	1.25%73.49M
Selling and administrative expenses	-2.42%61.17M	-20.34%13.1M	-14.29%13.92M	6.10%16.01M	21.65%18.14M	-0.85%62.68M	2.23%16.44M	11.98%16.24M	-8.45%15.09M	-7.68%14.91M
-General and administrative expense	-2.42%61.17M	-20.34%13.1M	-14.29%13.92M	6.10%16.01M	21.65%18.14M	-0.85%62.68M	2.23%16.44M	11.98%16.24M	-8.45%15.09M	-7.68%14.91M
Research and development costs	-6.34%234.06M	-23.38%50.71M	-12.33%57.09M	5.04%63.05M	7.91%63.22M	8.27%249.9M	27.76%66.18M	4.19%65.12M	-0.11%60.02M	3.81%58.58M
Operating profit	40.88%-118.99M	-11.50%-61.76M	-12.23%-61.61M	-57.92%-72.23M	269.25%76.61M	-9.79%-201.28M	-38.83%-55.39M	-13.33%-54.89M	6.09%-45.73M	2.25%-45.26M
Net non-operating interest income expense	17.71%11.1M	-59.43%1.49M	98.70%3.52M	6.02%2.8M	145.38%3.29M	76.43%9.43M	57.45%3.68M	112.11%1.77M	70.52%2.64M	114.72%1.34M
Non-operating interest income	17.71%11.1M	-59.43%1.49M	98.70%3.52M	----	----	76.43%9.43M	--3.68M	--1.77M	----	----
Total other finance cost	----	----	----	-6.02%-2.8M	-145.38%-3.29M	----	----	----	-70.52%-2.64M	-114.72%-1.34M
Other net income (expense)	-155.01M	-296K	-44.8M	-51.35M	-58.57M
Special income (charges)	---155.01M	---296K	---44.8M	---51.35M	---58.57M	--0	--0	--0	--0	--0
-Less:Impairment of capital assets	--155.01M	--296K	--44.8M	--51.35M	--58.57M	--0	--0	--0	--0	--0
Income before tax	-37.04%-262.9M	-17.12%-60.57M	-93.68%-102.89M	-180.27%-120.77M	148.56%21.33M	-7.79%-191.85M	-37.67%-51.71M	-11.60%-53.13M	8.61%-43.09M	3.85%-43.92M
Income tax	-1,282.28%-5.07M	-205.02%-272K	4,133.33%1.27M	-7,739.02%-6.26M	234.48%194K	40.20%429K	486.57%259K	-65.12%30K	241.67%82K	-77.86%58K
Net income	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.84%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.48%-43.17M	4.27%-43.98M
Net income continuous Operations	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.84%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.48%-43.17M	4.27%-43.98M
Minority interest income	0					0
Net income attributable to the parent company	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.85%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.47%-43.17M	4.26%-43.98M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-34.09%-257.83M	-16.01%-60.3M	-95.96%-104.16M	-165.23%-114.51M	148.05%21.13M	-7.85%-192.28M	-38.61%-51.97M	-11.46%-53.16M	8.47%-43.17M	4.26%-43.98M
Basic earnings per share	-18.40%-1.48	-6.25%-0.34	-73.53%-0.59	-127.59%-0.66	143.33%0.13	-1.63%-1.25	-23.08%-0.32	-3.03%-0.34	12.12%-0.29	6.25%-0.3
Diluted earnings per share	-18.40%-1.48	-6.25%-0.34	-73.53%-0.59	-127.59%-0.66	140.00%0.12	-1.63%-1.25	-23.08%-0.32	-3.03%-0.34	12.12%-0.29	6.25%-0.3
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall